AccentBio is an independent technology company that specialises in development of 1) novel assays and 2) novel therapeutics, particularly where these are related to therapies in Oncology and Women’s Health.

AccentBio identifies opportunities arising from innovative university research and prioritises the work required to achieve key milestones for the inventions. We work in partnership with the originating scientists and share any revenue generated through the commercialisation of technology from the collaboration.